Is the fluorescence optical imaging (FOI) able to discriminate between rheumatoid arthritis patients with and without need of rituximab retherapy? A cohort study

Is the fluorescence optical imaging (FOI) able to discriminate between rheumatoid arthritis patients with and without need of rituximab retherapy? A cohort study

Objective To evaluate the ability of fluorescence optical imaging (FOI) Xiralite in the discrimination between rheumatoid arthritis (RA) patients with and without need of rituximab (RTX) retherapy—in comparison to clinical, laboratory and musculoskeletal ultrasound parameters.Patients and methods Pa...

Full description

Bibliographic Details
Main Authors: Sandra Hermann, Gerd R Burmester, Sarah Ohrndorf, Marina Backhaus, Paula Hoff, Jens Klotsche, Anne-Marie Glimm, Schahrasad Lisa Ridha Ali, Gabriela Schmittat
Format: Article
Language:English
Published: BMJ Publishing Group 2021-08-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/11/8/e047713.full

Internet

https://bmjopen.bmj.com/content/11/8/e047713.full

Similar Items